SCHEMBL2540904

SCHEMBL2540904

CCOC(=O)c1sc(-n2cnc3cc(C=O)ccc32)nc1-c1cccc(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 1/20 0.46
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
DHODH Q02127 5/20 0.41
CFTR P13569 1/20 0.41
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRB2 P47870 1/20 0.39
HSD17B10 Q99714 1/20 0.39
JAK2 O60674 1/20 0.39
JAK3 P52333 1/20 0.39
HPGD P15428 1/20 0.38
CDC7 O00311 3/20 0.38
DBF4 Q9UBU7 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2540431 0.93 TRPM8 (0.46) TRPM8PDE4APDE4BPDE4CPDE4D
SCHEMBL2539441 0.82 AXL (0.44) TRPM8PDE4APDE4BPDE4CPDE4D
SCHEMBL2545221 0.79 TRPM8 (0.44) TRPM8PDE4APDE4BPDE4CPDE4D
SCHEMBL2543191 0.79 MEN1 (0.45) TRPM8PDE4APDE4BPDE4CPDE4D
SCHEMBL2546036 0.79 PLK1 (0.41) CDC7DBF4PLK1
SCHEMBL3888811 0.79 ALDH1A1 (0.52) TRPM8DHODHALDH1A1KDM4EHSD17B10
SCHEMBL2540391 0.78 TRPM8 (0.39) TRPM8PDE4APDE4BPDE4CPDE4D
SCHEMBL3894805 0.78 DHODH (0.53) DHODHALDH1A1HSD17B10HPGDCDC7
SCHEMBL2536649 0.77 AXL (0.44) TRPM8PDE4APDE4BPDE4CPDE4D
SCHEMBL3891536 0.77 ALDH1A1 (0.57) TRPM8DHODHALDH1A1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044213-B2 Thiazolyl-benzimidazoles HOFFMANN-LA ROCHE INC. (US) 2011-10-25 US disclosed
US-20100160308-A1 Thiazolyl-Benzimidazoles CAI JIANPING 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160308-A1 Thiazolyl-Benzimidazoles CYP3A7, CYP2C19, CYP3A5 TRPM8 2617/4885PDE4A 1791/4885PDE4B 1542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.